These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8863568)

  • 1. A statistical study of the American Urological Association symptom index for benign prostatic hyperplasia in participants of mass screening program for prostatic diseases using transrectal sonography.
    Ukimura O; Kojima M; Inui E; Ochiai A; Hata Y; Watanabe M; Saitoh M; Watanabe H
    J Urol; 1996 Nov; 156(5):1673-8. PubMed ID: 8863568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status.
    Jacobsen SJ; Jacobson DJ; Girman CJ; Roberts RO; Rhodes T; Guess HA; Lieber MM
    J Urol; 1999 Oct; 162(4):1301-6. PubMed ID: 10492184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence rates and risk factors for acute urinary retention: the health professionals followup study.
    Meigs JB; Barry MJ; Giovannucci E; Rimm EB; Stampfer MJ; Kawachi I
    J Urol; 1999 Aug; 162(2):376-82. PubMed ID: 10411042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study.
    Platz EA; Kawachi I; Rimm EB; Willett WC; Giovannucci E
    J Urol; 2000 Feb; 163(2):490-5. PubMed ID: 10647663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
    Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM
    J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Asian multinational prospective observational registry of patients with benign prostatic hyperplasia, with a focus on comorbidities, lower urinary tract symptoms and sexual function.
    Li MK; Garcia L; Patron N; Moh LC; Sundram M; Leungwattanakij S; Pripatnanont C; Cheng C; Chi-Wai M; Loi-Cheong N
    BJU Int; 2008 Jan; 101(2):197-202. PubMed ID: 18005205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The American Urological Association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate.
    Kojima M; Naya Y; Inoue W; Ukimura O; Watanabe M; Saitoh M; Watanabe H
    J Urol; 1997 Jun; 157(6):2160-5. PubMed ID: 9146607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple case definition of clinical benign prostatic hyperplasia, based on International Prostate Symptom Score, predicts general practitioner consultation rates.
    Kok ET; Bohnen AM; Jonkheijm R; Gouweloos J; Groeneveld FP; Thomas S; Bosch JL
    Urology; 2006 Oct; 68(4):784-9. PubMed ID: 17070353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
    Marks LS; Roehrborn CG; Wolford E; Wilson TH
    J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
    Helfand B; Mouli S; Dedhia R; McVary KT
    J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey.
    Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T
    Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
    Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
    Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.
    Eckhardt MD; van Venrooij GE; van Melick HH; Boon TA
    J Urol; 2001 Aug; 166(2):563-8. PubMed ID: 11458069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia.
    Homma Y; Yamaguchi T; Kondo Y; Horie S; Takahashi S; Kitamura T
    J Urol; 2002 Jan; 167(1):172-6. PubMed ID: 11743299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Kaplan SA; Walmsley K; Te AE
    J Urol; 2005 Dec; 174(6):2273-5. discussion 2275-6. PubMed ID: 16280803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening of clinical benign prostatic hypertrophy in general practice: survey of 18,540 men].
    Flam T; Montauban V
    Prog Urol; 2003 Jun; 13(3):416-24. PubMed ID: 12940193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia.
    St Sauver JL; Jacobson DJ; McGree ME; Lieber MM; Jacobsen SJ
    Am J Epidemiol; 2006 Oct; 164(8):760-8. PubMed ID: 16905643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.